Clinical implications of measurable residual disease in AML: Review of current evidence

Ine Moors*, Karl Vandepoele, Jan Philippé, Dries Deeren, Dominik Selleslag, Dimitri Breems, Nicole Straetmans, Tessa Kerre, Barbara Denys

*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical implications of measurable residual disease in AML: Review of current evidence'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology